# Internal Analgesic, Antipyretic, and Antirheumatic Drug Products for Over-The-Counter Human Use; Final Rule for Professional Labeling of Aspirin, Buffered Aspirin, and Aspirin in Combination With Antacid Drug Products; Correction
> **Food and Drug Administration** · Final rule; correction. · Published 1998-12-01 · Effective 1999-10-25 · 63 FR 66015
## Document
- **Document number:** 98-31854
- **Category:** other
- **Sub-agency:** Food and Drug Administration
- **Federal Register citation:** 63 FR 66015
- **CFR reference:** 21 CFR 343
- **Publication date:** 1998-12-01
- **Effective date:** 1999-10-25
- **HHS docket:** Docket No. 77N-094A
## Abstract

The Food and Drug Administration (FDA) is correcting a final rule that appeared in the Federal Register of October 23, 1998 (63 FR 56802). The document provided for professional labeling for over-the- counter (OTC) internal analgesic, antipyretic, and antirheumatic drug products containing aspirin, buffered aspirin, and aspirin in combination with an antacid. The document published with some inadvertent editorial errors. This document corrects those errors.

## Source
- [Federal Register document](https://www.federalregister.gov/documents/1998/12/01/98-31854/internal-analgesic-antipyretic-and-antirheumatic-drug-products-for-over-the-counter-human-use-final)
---
*AI Analytics · CC0 1.0*